Cargando…

468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study

Detalles Bibliográficos
Autores principales: Dubberke, Erik, Orenstein, Robert, Mariani, Paul, Mullane, Kathleen, Sobcinski, Mary Kay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782012/
http://dx.doi.org/10.1093/ofid/ofu052.334
_version_ 1783295092661944320
author Dubberke, Erik
Orenstein, Robert
Mariani, Paul
Mullane, Kathleen
Sobcinski, Mary Kay
author_facet Dubberke, Erik
Orenstein, Robert
Mariani, Paul
Mullane, Kathleen
Sobcinski, Mary Kay
author_sort Dubberke, Erik
collection PubMed
description
format Online
Article
Text
id pubmed-5782012
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57820122018-03-01 468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study Dubberke, Erik Orenstein, Robert Mariani, Paul Mullane, Kathleen Sobcinski, Mary Kay Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782012/ http://dx.doi.org/10.1093/ofid/ofu052.334 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Dubberke, Erik
Orenstein, Robert
Mariani, Paul
Mullane, Kathleen
Sobcinski, Mary Kay
468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
title 468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
title_full 468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
title_fullStr 468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
title_full_unstemmed 468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
title_short 468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
title_sort 468 rbx2660 (microbiota suspension) for recurrent c. difficile infection: 60-day interim analysis of the punch-cd phase 2 safety study
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782012/
http://dx.doi.org/10.1093/ofid/ofu052.334
work_keys_str_mv AT dubberkeerik 468rbx2660microbiotasuspensionforrecurrentcdifficileinfection60dayinterimanalysisofthepunchcdphase2safetystudy
AT orensteinrobert 468rbx2660microbiotasuspensionforrecurrentcdifficileinfection60dayinterimanalysisofthepunchcdphase2safetystudy
AT marianipaul 468rbx2660microbiotasuspensionforrecurrentcdifficileinfection60dayinterimanalysisofthepunchcdphase2safetystudy
AT mullanekathleen 468rbx2660microbiotasuspensionforrecurrentcdifficileinfection60dayinterimanalysisofthepunchcdphase2safetystudy
AT sobcinskimarykay 468rbx2660microbiotasuspensionforrecurrentcdifficileinfection60dayinterimanalysisofthepunchcdphase2safetystudy